Furthermore, it should be noted that the FAAs may also interact with other non-canonical receptors, such as PPARg (peroxisome proliferators activated receptor) and TRPV1 and 2 (Transient Receptor Potential Vanilloid type-1 and 2), which may play important roles in glioma pathophysiology and represent therapeutic targets [54,55]. This evidence concerns the gene PPARG and central nervous system cancer.